Blood Test for Neuroendocrine Differentiation
Order plasma chromogranin A (CgA) and 24-hour urinary 5-hydroxyindoleacetic acid (5-HIAA) as baseline tests when evaluating for neuroendocrine differentiation. These are the recommended first-line serum and urine markers for gastroenteropancreatic neuroendocrine tumors 1.
Primary Biomarkers
Chromogranin A (Plasma)
- CgA is the most practical general neuroendocrine marker, produced by all cells deriving from the neural crest 2
- Elevated in 60% or more of patients with functioning or nonfunctioning pancreatic neuroendocrine tumors 3
- Serves as a general NET marker across all gastroenteropancreatic sites 4
- Useful for diagnosis, treatment assessment, and prognostic information 2
5-HIAA (24-hour Urine Collection)
- Essential for small intestinal NETs (carcinoids), particularly midgut tumors where it is usually raised in 70% of patients 2
- Should be done in combination with plasma CgA assessments 4
Site-Specific and Syndrome-Specific Testing
Beyond baseline CgA and 5-HIAA, order specific biochemical tests based on clinical syndrome suspected 1:
For Gastrinoma (Zollinger-Ellison Syndrome)
- Fasting serum gastrin levels (basal and stimulated)
- Critical caveat: Stop proton pump inhibitors for at least 1 week before testing, as they falsely elevate gastrin 3, 5
- Gastrin >10 times elevated + gastric pH <2 is diagnostic 3
For Insulinoma
- Serum insulin, proinsulin, and C-peptide during hypoglycemia 3
- Insulin >3 mcIU/mL (usually >6) when glucose <55 mg/dL indicates insulinoma 3
- C-peptide ≥0.6 ng/mL and proinsulin ≥5 pmol/L support diagnosis 3
For Other Functional Tumors
- Glucagon for glucagonoma syndrome
- VIP for Verner-Morrison syndrome (WDHA)
- Pancreatic polypeptide (elevated in 80% of pancreatic tumors, 50% of carcinoids) 2
Additional Markers to Consider
Depending on clinical presentation, also consider 2:
- Calcium, thyroid function tests, PTH
- Calcitonin (for medullary thyroid carcinoma)
- Prolactin, α-fetoprotein, CEA, β-HCG
Important Caveats for Chromogranin A
Be aware of false positives that can spuriously elevate CgA levels 3:
- Proton pump inhibitor use (most common)
- Renal or liver failure
- Hypertension
- Chronic atrophic gastritis
For 5-HIAA testing, avoid these substances before collection as they cause false results 2:
- False positives: banana, avocado, eggplant, pineapple, plums, walnuts, acetaminophen, caffeine
- False negatives: levodopa, aspirin, methyldopa, phenothiazines
Prognostic Value
CgA levels ≥95 ng/mL are associated with shorter survival in metastatic NETs 6, and levels elevated twice normal or higher predict worse outcomes (HR 2.8) 3. Serial CgA measurements help monitor treatment response—a ≥30% decrease or normalization suggests tumor response 6.
Poorly Differentiated Tumors
In poorly differentiated G3 neuroendocrine carcinomas, plasma CgA is often normal; consider plasma NSE (neuron-specific enolase) as an alternative general marker in these cases 4.